(Q37622568)

21 August 2017

1 reference

title

The role of the central renin-angiotensin system in Parkinson's disease (English)

1 reference

21 August 2017

1 reference

Birgit Mertens

1

1 reference

21 August 2017

Patrick Vanderheyden

series ordinal

2

1 reference

21 August 2017

Yvette Michotte

series ordinal

3

1 reference

21 August 2017

Sophie Sarre

series ordinal

4

1 reference

21 August 2017

27 October 2009

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

21 August 2017

1 reference

21 August 2017

11

1 reference

21 August 2017

1

1 reference

21 August 2017

49-56

1 reference

The renin-angiotensin system in the brain: possible therapeutic implications for AT(1)-receptor blockers

21 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Angiotensin and renin in rat and dog brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Brain renin angiotensin in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Prospects for new restorative and neuroprotective treatments in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Neuroreplacement, growth factor, and small molecule neurotrophic approaches for treating Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Oxidative stress in neurodegeneration: cause or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Inflammation and angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

NAD(P)H oxidase: role in cardiovascular biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Reactive oxygen species as mediators of angiotensin II signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Angiotensin converting enzyme in the human basal forebrain and midbrain visualized by in vitro autoradiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Angiotensin-converting enzyme: new concepts concerning its biological role

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Association between genetic polymorphism of angiotensin-converting enzyme gene and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Substance P and Parkinson's disease: a causal relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

The ACE deletion polymorphism is not associated with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Effect of chronic angiotensin-converting enzyme inhibition on striatal dopamine content in the MPTP-treated mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Redox signaling in central neural regulation of cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Angiotensin II type 1 receptor-mediated peroxide production in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Protective effect of captopril and enalaprilat, angiotensin-converting enzyme inhibitors, on para-nonylphenol-induced *OH generation and dopamine efflux in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Why do antioxidants fail to provide clinical benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Angiotensin receptors in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Changes in angiotensin II receptors in dopamine-rich regions of the mouse brain with age and ethanol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

The AT2 receptor--a matter of love and hate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Use of antihypertensives and the risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Expression of AT2 receptors in the developing rat fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Mapping of angiotensin II receptor subtype heterogeneity in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Distribution of angiotensin II type-2 receptor (AT2) mRNA expression in the adult rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

The CNS renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

The angiotensin type 2 receptor of angiotensin II and neuronal differentiation: from observations to mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Angiotensin II and NGF differentially influence microtubule proteins in PC12W cells: role of the AT2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Differential role of angiotensin II receptor subtypes on endothelial superoxide formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Angiotensin II protects against alpha-synuclein toxicity and reduces protein aggregation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320309347789

21 January 2018

Identifiers

DOI

10.1177/1470320309347789

1 reference

21 August 2017

1 reference